Annual Shareholders Equity
$16.95 M
-$8.69 M-33.89%
December 31, 2023
Summary
- As of February 22, 2025, APRE annual stockholders equity is $16.95 million, with the most recent change of -$8.69 million (-33.89%) on December 31, 2023.
- During the last 3 years, APRE annual shareholders equity has fallen by -$60.44 million (-78.09%).
- APRE annual shareholders equity is now -86.35% below its all-time high of $124.24 million, reached on December 31, 2019.
Performance
APRE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$21.95 M
-$3.61 M-14.13%
September 30, 2024
Summary
- As of February 22, 2025, APRE quarterly stockholders equity is $21.95 million, with the most recent change of -$3.61 million (-14.13%) on September 30, 2024.
- Over the past year, APRE quarterly shareholders equity has dropped by -$6.98 million (-24.12%).
- APRE quarterly shareholders equity is now -82.34% below its all-time high of $124.24 million, reached on December 31, 2019.
Performance
APRE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
APRE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.9% | -24.1% |
| 3 y3 years | -78.1% | -58.9% |
| 5 y5 years | +133.0% | +131.0% |
APRE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.8% | at low | -55.7% | +161.3% |
| 5 y | 5-year | -86.3% | at low | -82.3% | +161.3% |
| alltime | all time | -86.3% | +133.0% | -82.3% | +131.0% |
Aprea Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.95 M(-14.1%) |
| Jun 2024 | - | $25.56 M(-11.6%) |
| Mar 2024 | - | $28.92 M(+70.6%) |
| Dec 2023 | $16.95 M(-33.9%) | $16.95 M(-16.4%) |
| Sep 2023 | - | $20.29 M(-13.4%) |
| Jun 2023 | - | $23.42 M(-11.6%) |
| Mar 2023 | - | $26.48 M(+3.3%) |
| Dec 2022 | $25.64 M(-48.2%) | $25.64 M(-3.7%) |
| Sep 2022 | - | $26.63 M(-174.4%) |
| Jun 2022 | - | -$35.78 M(-182.1%) |
| Mar 2022 | - | $43.59 M(-12.0%) |
| Dec 2021 | $49.51 M | $49.51 M(-7.3%) |
| Sep 2021 | - | $53.42 M(-12.4%) |
| Jun 2021 | - | $60.95 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $69.15 M(-10.7%) |
| Dec 2020 | $77.40 M(-37.7%) | $77.40 M(-13.1%) |
| Sep 2020 | - | $89.02 M(-11.1%) |
| Jun 2020 | - | $100.12 M(-11.7%) |
| Mar 2020 | - | $113.35 M(-8.8%) |
| Dec 2019 | $124.24 M(-341.5%) | $124.24 M(-275.5%) |
| Sep 2019 | - | -$70.80 M(-225.7%) |
| Jun 2019 | - | $56.34 M(-209.5%) |
| Dec 2018 | -$51.44 M(+43.8%) | -$51.44 M |
| Dec 2017 | -$35.77 M(+1592.1%) | - |
| Jun 2008 | -$2.11 M(+86.4%) | - |
| Jun 2007 | -$1.13 M(-37.0%) | - |
| Jun 2006 | -$1.80 M(>+9900.0%) | - |
| Dec 2004 | -$3300.00 | - |
FAQ
- What is Aprea Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aprea Therapeutics?
- What is Aprea Therapeutics annual shareholders equity year-on-year change?
- What is Aprea Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly shareholders equity year-on-year change?
What is Aprea Therapeutics annual stockholders equity?
The current annual shareholders equity of APRE is $16.95 M
What is the all time high annual shareholders equity for Aprea Therapeutics?
Aprea Therapeutics all-time high annual stockholders equity is $124.24 M
What is Aprea Therapeutics annual shareholders equity year-on-year change?
Over the past year, APRE annual stockholders equity has changed by -$8.69 M (-33.89%)
What is Aprea Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of APRE is $21.95 M
What is the all time high quarterly shareholders equity for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly stockholders equity is $124.24 M
What is Aprea Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, APRE quarterly stockholders equity has changed by -$6.98 M (-24.12%)